CHARACTERIZATION OF A NOVEL HYPOXIA-ASSOCIATED MOLECULAR THERAPEUTIC TARGET FOR LOCALLY ADVANCED PROSTATE CANCER

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators